Growth Metrics

Pyxis Oncology (PYXS) Other Gross PP&E Adjustments (2020 - 2025)

Pyxis Oncology (PYXS) reported Other Gross PP&E Adjustments of $2.8 million for Q4 2025, up 10.6% year-over-year from $2.5 million in Q4 2024, and up 123.85% on a QoQ basis from -$11.6 million in Q3 2025.

Pyxis Oncology (PYXS) has 6 years of Other Gross PP&E Adjustments data on file, last reported at $2.8 million in Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 10.6% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (up 10.6% YoY) and the FY2025 annual result came in at $2.8 million, up 10.6% from the prior year.
  • Other Gross PP&E Adjustments climbed to $2.8 million in Q4 2025 per PYXS's latest filing, from -$11.6 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $2.8 million in Q4 2025 and bottomed at -$15.0 million in Q2 2022.
  • The 5-year median for Other Gross PP&E Adjustments is -$11.8 million (2025), against an average of -$7.5 million.
  • The widest annual swing landed in 2022, when Other Gross PP&E Adjustments tumbled 3687.63%; it then surged 171.9% in 2023.
  • Tracing PYXS's Other Gross PP&E Adjustments over 5 years: stood at $909000.0 in 2021, then sank by 364.69% to -$2.4 million in 2022, then soared by 171.9% to $1.7 million in 2023, then jumped by 45.09% to $2.5 million in 2024, then climbed by 10.6% to $2.8 million in 2025.
  • Per Business Quant, the three latest PYXS Other Gross PP&E Adjustments figures stand at $2.8 million (Q4 2025), -$11.6 million (Q3 2025), and -$11.8 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -83,048.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -60,691.22
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -892,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -1.69 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -189.30 Mn
10 Pyxis Oncology 120.87 Mn 103.97 Mn 8.65 Mn 2.78 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.78 Mn
Dec 31, 2025 2.78 Mn
Sep 30, 2025 -11.64 Mn
Sep 30, 2025 -11.64 Mn
Jun 30, 2025 -11.85 Mn
Jun 30, 2025 -11.85 Mn
Mar 31, 2025 -12.05 Mn
Mar 31, 2025 -12.05 Mn
Dec 31, 2024 2.51 Mn
Dec 31, 2024 2.51 Mn
Mar 31, 2024 -12.78 Mn
Mar 31, 2024 -12.78 Mn
Dec 31, 2023 1.73 Mn
Dec 31, 2023 1.73 Mn
Sep 30, 2023 -13.13 Mn
Sep 30, 2023 -13.13 Mn
Jun 30, 2023 -13.28 Mn
Jun 30, 2023 -13.28 Mn
Mar 31, 2023 -13.46 Mn
Mar 31, 2023 -13.46 Mn
Dec 31, 2022 -2.41 Mn
Dec 31, 2022 -2.41 Mn
Sep 30, 2022 -14.70 Mn
Sep 30, 2022 -14.70 Mn
Jun 30, 2022 -15.00 Mn
Jun 30, 2022 -15.00 Mn
Dec 31, 2021 909,000.00
Dec 31, 2021 909,000.00
Sep 30, 2021 -388,000.00
Sep 30, 2021 -388,000.00
Dec 31, 2020 569,000.00
Dec 31, 2020 569,000.00